Anti NMDAR autoimmune encephalitis: clinical features
Evidence-based neurology checklist on anti nmdar autoimmune encephalitis: clinical features: Epidemiology The median onset age is about 22 years: the age range is 5-76 years Females account for 70-90% of cases Triggers Encephalitic features Movement disorders Sleep disorders Psychiatric features…
Epidemiology
- The median onset age is about 22 years: the age range is 5-76 years
- Females account for 70-90% of cases
Triggers
Encephalitic features
Movement disorders
Sleep disorders
Psychiatric features
Systemic features
References
- Dalmau J, Glelchman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case serious and analysis of the effects of antibodies. Lancet Neurol 2008; 7:1091-1098.
- Irani SR, Bera K, Waters P, et al. N-methyl-D-aspartase antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 2010; 133:1655-1667.
- Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 2016; 15:391-404.
- Nosadini M, Mohammad SS, Corazza F, et al. Herpes simplex virus-induced anti-N-methyl-D-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases. Dev Med Child Neurol 2017; 59:796-805.
- Hacohen Y, Deiva K, Pettingill P, et al. N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse. Mov Disord 2014; 29:90-96.
- And 23 more. Subscribe to see the full list
Related checklists
- Anti NMDAR autoimmune encephalitis: atypical features
- Anti NMDAR autoimmune encephalitis: associated cancers
- Anti NMDAR autoimmune encephalitis: differential diagnosis
- Anti NMDAR autoimmune encephalitis: outcomes
- Anti NMDAR autoimmune encephalitis: investigations
- Anti NMDAR autoimmune encephalitis: treatment